Dry Granulation Binders, Products, and Use Thereof
Abstract
A method for the preparation of microcrystalline cellulose containing tablets by roller compaction followed by tabletting is disclosed. A tablet formulation is converted to a dry granulate by roller compaction, and the dry granulate lubricated dry granulate and compacted to a tablet. The tablet formulation comprises at least one active, an microcrystalline cellulose containing material, and, optionally other pharmaceutically acceptable excipients. The microcrystalline cellulose containing material has a maximum primary compaction tensile strength of at least 9 MPa or at least 9.5 MPa and a secondary compaction tensile strength of at least 5 MPa, at least 5.5 MPa, or at least 6 MPa. A method for evaluating binders is also disclosed.
Claims
exact text as granted — not AI-modified1 . A composition, wherein:
the composition comprises at least 60 wt % of a microcrystalline cellulose containing material; the composition has a primary tensile strength of at least 9.5 MPa after a primary compaction at 250 MPa; and the composition has a secondary tensile strength of at least 5.5 MPa after a primary compaction at 250 MPa and a secondary compaction at 250 MPa.
2 . The composition of claim 1 in which:
the microcrystalline cellulose containing material is microcrystalline cellulose co-processed with at least one sugar alcohol,
the ratio of microcrystalline cellulose to the at least one sugar alcohol is about 70:30 to about 95:5, and
the at least one sugar alcohol has at least four carbon atoms.
3 . The composition of claim 2 in which the at least one sugar alcohol is mannitol.
4 . The composition of claim 3 in which the composition comprises at least 65 wt % of the microcrystalline cellulose containing material.
5 . A granulate formulation comprising the composition of claim 1 , at least one active, and at least one lubricant.
6 . The granulate formulation of claim 5 in which the microcrystalline cellulose containing material is microcrystalline cellulose co-processed with mannitol.
7 .- 9 . (canceled)
10 . A method comprising the steps of:
applying pressure to a granulate formulation to form a compact, and milling the compact to form a granulate; wherein: the granulate formulation comprises a binder composition, at least one active, at least one excipient, and at least one lubricant, the binder composition comprises at least 60 wt % of a microcrystalline cellulose containing material, and either (1) the binder composition has a maximum primary tensile strength of at least 9.5 MPa after a primary compaction at 250 MPa and a secondary tensile strength of at least 5.5 MPa after a primary compaction at 250 MPa and a secondary compaction at 250 MPa, or (2) the microcrystalline cellulose containing material is microcrystalline cellulose co-processed with a material selected from the group consisting of sugar alcohols and carboxymethyl cellulose, the binder composition has a maximum primary tensile strength of at least 9.0 MPa after a primary compaction at 250 MPa and a secondary tensile strength of at least 5.0 MPa after a primary compaction at 250 MPa and a secondary compaction after a primary compaction at 250 MPa.
11 . The method of claim 10 in which:
the microcrystalline cellulose containing material is microcrystalline cellulose co-processed with at least one sugar alcohol,
the ratio of microcrystalline cellulose to the at least one sugar alcohol is about 70:30 to about 95:5, and
the at least one sugar alcohol has at least four carbon atoms.
12 . The method of claim 11 in which the at least one sugar alcohol is mannitol.
13 . The method of claim 10 in which the microcrystalline cellulose containing material is microcrystalline cellulose co-processed with carboxymethyl cellulose.
14 . The method of claim 10 in which the step of applying pressure is carried out by roller compaction.
15 . The method of claim 10 additionally comprising the step of compacting the granules to form a solid dosage form.
16 . A solid dosage form prepared by the method of claim 15 .
17 . The solid dosage form of claim 16 in which in which the microcrystalline cellulose containing material is microcrystalline cellulose co-processed with mannitol, and the ratio of microcrystalline cellulose to mannitol is about 70:30 to about 95:5.
18 . The solid dosage form of claim 17 in which the solid dosage form has a tensile strength of at least 2 MPa.
19 . The solid dosage form of claim 16 in which in which the microcrystalline cellulose containing material is microcrystalline cellulose co-processed with carboxymethyl cellulose.
20 . The solid dosage form of claim 19 in which the solid dosage form has a tensile strength of at least 2 MPa.
21 . A method of evaluating binders, in which the binder comprises at least about 40 wt % of a microcrystalline cellulose containing material; the method comprising the steps of:
1) compacting the binder at 250 Pa and measuring the primary tensile strength; 2) compacting the binder formed in step 1) at 250 Pa and measuring the secondary tensile strength; and 3) selecting binders that in which either (1) the binder has a primary tensile strength of at least 9.5 MPa and a secondary tensile strength of at least 6 MPa; or (2) the microcrystalline cellulose containing material is microcrystalline cellulose co-processed with a material selected from the group consisting of sugar alcohols and carboxymethyl cellulose, and the binder has a maximum primary tensile strength of at least 9.0 MPa and a secondary tensile strength of at least 5.0 MPa.
22 . The method of claim 21 in which the binder comprises at least about 60 wt % microcrystalline celluloseCited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.